-
1.
公开(公告)号:EP3478677A1
公开(公告)日:2019-05-08
申请号:EP17737708.2
申请日:2017-06-29
申请人: The U.S.A. as represented by the Secretary, Department of Health and Human Services , Vanderbilt University , The UAB Research Foundation , The Trustees of The University of Pennsylvania
发明人: MALONEY, David J. , WATERSON, Alex Gregory , BANTUKALLU, Ganesha Rai , BRIMACOMBE, Kyle Ryan , CHRISTOV, Plamen , DANG, Chi V. , DARLEY-USMAR, Victor M. , HALL, Matthew , HU, Xin , JADHAV, Ajit , JANA, Somnath , KIM, Kwangho , MOORE, William J. , MOTT, Brian T. , NECKERS, Leonard M. , SIMEONOV, Anton , SULIKOWSKI, Gary Allen , URBAN, Daniel Jason , YANG, Shyh Ming
IPC分类号: C07D417/04 , C07D417/14 , A61K31/427 , A61P35/00 , A61P11/00
-
2.PIPERIDINE AND PIPERAZINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS AND CANCER 审中-公开
标题翻译: 哌啶和哌嗪衍生物和它们的病毒感染和癌症的治疗公开(公告)号:EP3074001A1
公开(公告)日:2016-10-05
申请号:EP14809235.6
申请日:2014-11-20
发明人: LIANG, Tsanyang Jake , FERRER, Marc , HE, Shanshan , HU, Xin , HU, Zongyi , MARUGAN, Juan Jose , SOUTHALL, Noel Terrence , XIAO, Jingbo , ZHENG, Wei
IPC分类号: A61K31/12 , A61K35/00 , A61K31/4468 , A61K31/4465 , A61K31/445 , A61K31/4995 , C07D243/08 , C07D295/073 , C07D295/088 , C07D295/096 , C07D295/185 , C07D209/48 , A61P31/12 , A61P35/00
CPC分类号: C07D405/10 , A61K31/4409 , A61K31/4465 , A61K31/4468 , A61K31/453 , A61K31/495 , A61K31/496 , A61K31/55 , A61K45/06 , C07D209/48 , C07D211/12 , C07D211/14 , C07D211/58 , C07D213/16 , C07D243/08 , C07D295/03 , C07D295/073 , C07D295/088 , C07D295/096 , C07D295/185 , C07D403/12
摘要: Disclosed are compounds of formula (I) (formula I),as antiviral agents, antineoplastic agents, pharmaceutical compositions comprising such compounds, and a method of use of these compounds, wherein X and Y are independently CH or N, o is 0, 1 or 2, and E is absent or is (CR
13 R
14 )m, NH, or S, F is absent or is (CR
15 R
16 )n, C=O, or -SO
2 -, G is absent or is (CR
17 CR
18 )r, H is absent or is C=O, or -SO
2 - and R
1 , Ar
1 , Ar
2 are as defined in the specification. These compounds are antiviral agents and are contemplated in the treatment of viral infections, for example, hepatitis C, or are antineoplastic agents.摘要翻译: 本发明公开了式(I)(式I),作为抗病毒剂,抗肿瘤剂,药物组合物,包含检查化合物,和使用合成的化合物的方法,worin X和Y独立地是CH或N,o为0,1的化合物 或2,e是不存在或(CR 13 R 14)米,NH或S,R不存在或为(CR 15 R 16)N,C = O,或-SO 2 - ,G是不存在或为(CR17 CR18)R H是不存在或为C = O,-SO 2或 - 且R 1中,Ar 1中,Ar 2是如说明书中所定义。 这些化合物的抗病毒剂和病毒感染的治疗被预期,例如,丙型肝炎,或是抗肿瘤剂。
-
3.HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF 审中-公开
标题翻译: VERBINDUNGEN VERBINDUNGEN VERFAHREN ZUR VERWENDUNG DAVON公开(公告)号:EP3154966A1
公开(公告)日:2017-04-19
申请号:EP15730666.3
申请日:2015-06-12
申请人: The U.S.A. as represented by the Secretary, Department of Health and Human Services , University of Kansas
发明人: LIANG,Tsanyang , HU, Zongyi , MARUGAN, Juan Jose , SOUTHALL, Noel Terrence , HE, Shanshan , HU, Xin , XIAO, Jingbo , FERRER, Marc , ZHENG, Wei , FRANKOWSKI, Kevin J. , SCHOENEN, Frank J. , LI, Kelin
IPC分类号: C07D413/14 , C07D471/08 , A61K31/553 , A61P31/14
CPC分类号: C07D413/06 , A61K31/4178 , A61K31/454 , A61K31/4545 , A61K31/496 , A61K31/5377 , A61K31/7056 , A61K31/7068 , A61K38/07 , A61K38/13 , A61K38/212 , C07D413/14 , C07D417/14 , C07D471/08 , Y02A50/385
摘要: Disclosed are compounds of formula (I), formula (II), and formula (III): wherein Ar, R1, A, and X are as defined in the specification. These compounds are antiviral agents and are contemplated for use in the treatment of viral infections, for example, hepatitis C. These compounds are also contemplated for use in treating or preventing cancers.
摘要翻译: 公开了式(I),式(II)和式(III)的化合物:其中Ar,R 1,A和X如说明书中所定义。 这些化合物是抗病毒剂,并且被考虑用于治疗病毒感染,例如丙型肝炎。这些化合物也被考虑用于治疗或预防癌症。
-
公开(公告)号:EP3154966B1
公开(公告)日:2019-05-08
申请号:EP15730666.3
申请日:2015-06-12
申请人: The U.S.A. as represented by the Secretary, Department of Health and Human Services , University of Kansas
发明人: LIANG,Tsanyang , HU, Zongyi , MARUGAN, Juan Jose , SOUTHALL, Noel Terrence , HE, Shanshan , HU, Xin , XIAO, Jingbo , FERRER, Marc , ZHENG, Wei , FRANKOWSKI, Kevin J. , SCHOENEN, Frank J. , LI, Kelin
IPC分类号: C07D413/14 , C07D471/08 , A61K31/553 , A61P31/14
-
-
-